PT-141 (Bremelanotide) is a synthetic peptide developed to treat sexual dysfunction. It works by activating melanocortin receptors in the brain, enhancing sexual arousal and libido in both men and women. Unlike other treatments, PT-141 affects desire rather than blood flow, and it’s FDA-approved for treating hypoactive sexual desire disorder (HSDD) in premenopausal women.
Reviews
There are no reviews yet.